Zürich, Switzerland, November 16, 2023 (Business Wire) -- Memo Therapeutics AG (“MTx”), a late-stage biotech firm advancing top-tier therapeutic antibodies, discloses the appointment of Erik van den Berg as Chief Executive Officer (CEO).
Read full article here.
South San Francisco, CA, November 18, 2024 (Globe Newswire) -- Zenflow, Inc., a leader in medical device innovation for urological...
Philadelphia, November 14, 2024 (PRNewswire) -- Nobias Therapeutics has named Patrick Dougherty as its Chief Executive Officer, marking...
New York, November 13, 2024 (Business Wire) -- Metsera has raised $215 million in Series B financing, led by Wellington Management and...
Comentarios